| Business Name: |
Aponte Jr Josef H MD |
| Contact Person: |
Josef Aponte Jr |
| Address: |
951 North Washington Avenue, Titusville, Florida 32796 |
| Phone Number: |
(321) 268-6111 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Hate' Vidya N MD - Titusville, FL 32796
Tewatia Tarun MD - Titusville, FL 32796
Conty Alex MD - Titusville, FL 32796
Pobi Kwabena K MD - Titusville, FL 32796
Rylander William F MD - Titusville, FL 32796
Spitz Anita D MD - Titusville, FL 32796
Elias Samir MD - Titusville, FL 32796
Rashid Ayesha I MD - Titusville, FL 32796
Vargas Charlene MD - Titusville, FL 32796
Glenn James D MD - Titusville, FL 32796
Alexander Patricia MD - Titusville, FL 32796
Johnson Deniz MD - Titusville, FL 32796
Ochoa Karin A MD - Titusville, FL 32796
Prendergast Brendan M MD - Titusville, FL 32796
Mody Naresh V MD - Titusville, FL 32796
Bryant Cynthia MD - Titusville, FL 32796
Florida Eye Assoc - Titusville, FL 32796
Parrish Medical Group - Titusville, FL 32796
Modi Kiran R MD - Titusville, FL 32796
Nichols Jr James T MD - Titusville, FL 32796
|
The company Aponte Jr Josef H MD provides B2C services in the form of Doctors from its single location in Florida.
1 to 4 employees work for Aponte Jr Josef H MD, and the business now earns $500.000 to $999.999 per annum.
Aponte Jr Josef H MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Aponte Jr Josef H MD, please call Josef Aponte Jr with the phone number (321) 268-6111 or visit its single location at 951 North Washington Avenue in Titusville, Florida 32796.
The location of the single location can also be found using the coordinates 28.62755,-80.82398.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.